Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
I see WQ increased to 1.10% on the 10th
Just hope they get stung as been working for them so far. MCAP ridiculous.
770k shares have got be brought back at some point. Let’s hope it costs them over £4.50 … the B’s
Soder what is the basis of your call for the bottom? Do you feel that the sentiment has changed because of the Indian variant?
I just feel it hit a low resistance and had a jerk of a reaction. I dont think the Indian variant would have caused sentiment to change as its been around for a few days and nothing changed.
Hi B2 nice information on the competition thanks for posting.
For the record here is info on genomic surveillance assays from other manufacturers, with dates they were first announced.
None have FDA authorisations to date, so are Research Use Only by default.
+++
https://perkinelmer-appliedgenomics.com/home/sars-cov-2-testing-solutions/sars-cov-2-variants/
NGS = Next Generation Sequencing
https://perkinelmer-appliedgenomics.com/home/sars-cov-2-testing-solutions/nextflex-variant-seq-sars-cov-2-kit/
Note 7 hour process duration.
+++
26.03.21 -
Roche launches test to monitor emerging coronavirus variants
https://pharmaphorum.com/news/roche-launches-test-to-monitor-emerging-coronavirus-variants/
Roche has launched a new test that will help monitor emerging variants of the SARS-CoV-2 coronavirus.
In a statement the company said the cobas SARS-CoV-2 Variant Set 1 Test is designed to detect key spike mutations in virus variants associated with increased human-to-human transmission.
+++
10.03.2021 -
https://thermofisher.mediaroom.com/2021-03-10-Thermo-Fisher-Scientific-Launches-Customizable-TaqMan-SARS-CoV-2-Mutation-Panel
Thermo-Fisher launches Customizable TaqMan SARS-CoV-2 Mutation Panel.
These are the details, - Variants and sub-variants, but not the Bristol or California variants:
https://www.thermofisher.com/uk/en/home/clinical/clinical-genomics/pathogen-detection-solutions/real-time-pcr-research-solutions-sars-cov-2/mutation-panel.html?cid=fl-mutationpanel#orderinginfo
I should think positive fully audited results due end of June, a positive forward looking statement, AND, hopefully a relisting onto a decent market away from AIM would do wonders.
I think it's coming.
I wonder what the harm would be in announcing that a company was involved if they were.
We accept that NCYT could be involved but they probably can't say because they are probably bounded by a NDA, like we accepted the lack of news on a DHSC renewal was probably for the same reason. Why do we have to make these allowances?
I've read comparisons between Mcap now and last August, written with incredulity at the inequity of the valuation, with £150m in the bank & all the positives. In a real world, the uninvested market, or an auditor in Deloitte, has obvious questions about revenue, business plan & legal exposure that they need answering to improve their opinions. The business needs to step up on its basic homework for the market to see where it stands IMO & end all this mystery.
Yes, within the UK all positive samples are being sequenced, although not clear whether this is being done by the traditional method or via PCR assay.
I am a bit ill informed re variant testing.
If they are doing surge testing in Bolton specifically for the Indian variant will every positive test be then checked and tested for the variant? Who else can do that apart from our assay?
I agree with that Soder, market turbulance increases volatility and increases volume and the spread for sure. I don't see positive or negative wider markets driving NCYT's day by day price action though, at least not to a large extent. We are beholden to covid sentiment for better or worse. Reopening etc has dampened the covid appetite, albeit in my view thats counter intuitive, given more opening equals more cases and testing. Now cases are increasing again sentiment is swinging back to us.
As a former mkt maker albeit on bonds I can assure you that you use any wider market turbulence to create as much vol as possible to drive flows and increase b/o
Markets are irrelevant to NCYT in my view. Theyve been booming whilst we've been losing 70%. Positive market sentiment does not correlate with NCYT. Covid has its own sentiment bubble, and with the news of the Indian variant starting to surge in the UK, thats been our trigger I believe. That and a classic double bottom this morning.
European stocks now higher on day after being down 1.5%. Huge huge reversal across the board.
great to see blue for a change...Vive la bleu!
Let’s hope so - but yes it did feel like a stop hunt this morning.
Flushed.
It’s a long road back. And there will be bumps. But I got a feeling that was the final shake.
I hate calling a bottom. But I think that dip this morning was it. The final flush. It dipped and was bought and bounced v quickly. Have seen small high volume sells to hold back slightly but I think that IMO we just saw the final wash.